查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1212226

檢體有效性實驗的全球市場

Specimen Validity Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 173 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球檢體有效性實驗的市場規模預測將從2022年的26億美元，到2030年達到39億美元，在2022年～2030年間預計將以5.2％的年複合成長率成長。

本報告提供全球檢體有效性測試市場調查分析，提供市場概要，市場趨勢，各地區的市場分析，競爭情形等系統性資訊。

調查對象企業範例(計42公司):

  • Acm Global Laboratories
  • Alfa Scientific Designs, Inc.
  • Clinical Reference Laboratory, Inc.
  • Express Diagnostics Int'l, Inc.
  • Premier Brands of America, Inc.
  • Quest Diagnostics, Inc.
  • Sciteck, Inc.
  • Thermo Fisher Scientific, Inc.

目錄

第1章 調查手法

第2章 摘要整理

  • 市場概要
  • 主要企業
  • 市場趨勢與推動因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 其他地區

第4章 競爭

簡介目錄
Product Code: MCP14972

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Specimen Validity Testing Market to Reach $3.9 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Specimen Validity Testing estimated at US$2.6 Billion in the year 2022, is projected to reach a revised size of US$3.9 Billion by 2030, growing at aCAGR of 5.2% over the period 2022-2030. Products, one of the segments analyzed in the report, is projected to record 4.6% CAGR and reach US$2.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Services segment is readjusted to a revised 6.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $756.4 Million, While China is Forecast to Grow at 4.9% CAGR

The Specimen Validity Testing market in the U.S. is estimated at US$756.4 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$683.2 Million by the year 2030 trailing a CAGR of 4.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.7% and 4.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.

Select Competitors (Total 42 Featured):

  • Acm Global Laboratories
  • Alfa Scientific Designs, Inc.
  • Clinical Reference Laboratory, Inc.
  • Express Diagnostics Int'l, Inc.
  • Premier Brands of America, Inc.
  • Quest Diagnostics, Inc.
  • Sciteck, Inc.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Specimen Validity Testing Market: Overview & Outlook
    • Specimen Validity Testing - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increased Prevalence of Substance Abuse: Major Growth Driver
    • Governmental Efforts to Alleviate Drug Abuse Builds Robust Business Case
    • Increased Emphasis on Workplace Drug Testing Augurs Well
    • Saliva Drug Testing: More Suitable for Workplace Testing
    • Emphasis on Creating A Drug-Free Workplace
    • Marijuana Testing Gathers Pace
    • Relevance of Drug Testing for Medical Professionals Drives Demand
    • Increased Opportunities in Alcohol Testing Vertical
    • Growing Use Case in Rehabilitation Centers
    • Regulations
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Laboratory Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Laboratory Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Laboratory Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Workplaces by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Workplaces by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Workplaces by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Drug Screening Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Drug Screening Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Drug Screening Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Pain Management Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Pain Management Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Pain Management Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Drug Rehabilitation Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Drug Rehabilitation Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Drug Rehabilitation Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Specimen Validity Testing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Specimen Validity Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Specimen Validity Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 22: World 16-Year Perspective for Specimen Validity Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 25: World 16-Year Perspective for Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 28: World 16-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Rapid / POC Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Rapid / POC Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 31: World 16-Year Perspective for Rapid / POC Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Law Enforcement Agencies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Law Enforcement Agencies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 34: World 16-Year Perspective for Law Enforcement Agencies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Specimen Validity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid / POC Testing for the Years 2014, 2023 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Specimen Validity Testing by Offering - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Specimen Validity Testing by Offering - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Specimen Validity Testing by Offering - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid / POC Testing for the Years 2014, 2023 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Specimen Validity Testing by Offering - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Specimen Validity Testing by Offering - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Specimen Validity Testing by Offering - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2023 & 2030
  • JAPAN
    • Specimen Validity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid / POC Testing for the Years 2014, 2023 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Specimen Validity Testing by Offering - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Specimen Validity Testing by Offering - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Specimen Validity Testing by Offering - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2023 & 2030
  • CHINA
    • Specimen Validity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 64: China 16-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid / POC Testing for the Years 2014, 2023 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 67: China 16-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Specimen Validity Testing by Offering - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Specimen Validity Testing by Offering - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 70: China 16-Year Perspective for Specimen Validity Testing by Offering - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2023 & 2030
  • EUROPE
    • Specimen Validity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid / POC Testing for the Years 2014, 2023 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Specimen Validity Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Specimen Validity Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Specimen Validity Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Specimen Validity Testing by Offering - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Specimen Validity Testing by Offering - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Specimen Validity Testing by Offering - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2023 & 2030
  • FRANCE
    • Specimen Validity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 85: France 16-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid / POC Testing for the Years 2014, 2023 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 88: France 16-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Specimen Validity Testing by Offering - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Specimen Validity Testing by Offering - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 91: France 16-Year Perspective for Specimen Validity Testing by Offering - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2023 & 2030
  • GERMANY
    • Specimen Validity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid / POC Testing for the Years 2014, 2023 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Specimen Validity Testing by Offering - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Specimen Validity Testing by Offering - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Specimen Validity Testing by Offering - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid / POC Testing for the Years 2014, 2023 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Specimen Validity Testing by Offering - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Specimen Validity Testing by Offering - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Specimen Validity Testing by Offering - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Specimen Validity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid / POC Testing for the Years 2014, 2023 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Specimen Validity Testing by Offering - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Specimen Validity Testing by Offering - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Specimen Validity Testing by Offering - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid / POC Testing for the Years 2014, 2023 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Specimen Validity Testing by Offering - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Specimen Validity Testing by Offering - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Specimen Validity Testing by Offering - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Specimen Validity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid / POC Testing for the Years 2014, 2023 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Specimen Validity Testing by Offering - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Specimen Validity Testing by Offering - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Specimen Validity Testing by Offering - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Specimen Validity Testing by Type - Laboratory Testing and Rapid / POC Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Specimen Validity Testing by Type - Percentage Breakdown of Value Sales for Laboratory Testing and Rapid / POC Testing for the Years 2014, 2023 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Specimen Validity Testing by End-Use - Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Specimen Validity Testing by End-Use - Percentage Breakdown of Value Sales for Workplaces, Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Law Enforcement Agencies and Other End-Uses for the Years 2014, 2023 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Specimen Validity Testing by Offering - Products and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Specimen Validity Testing by Offering - Products and Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Specimen Validity Testing by Offering - Percentage Breakdown of Value Sales for Products and Services for the Years 2014, 2023 & 2030

IV. COMPETITION